The invention is directed to intermediates useful for making indazole compounds that modulate and/or inhibit cell proliferation.

 
Web www.patentalert.com

< Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination

< Agent for treating eye diseases

> Substituted biaryl quinolin-4-ylamine analogues

> Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
~ 00263